Correction to Lancet Oncol 2024; 25: 1188–201

The Lancet Oncology Pub Date : 2024-10-30 DOI:10.1016/s1470-2045(24)00635-1

引用次数: 0

Abstract

Karpinski MJ, Hüsing J, Claassen K, et al Combining PSMA-PET and PROMISE to re-define disease stage and risk in patients with prostate cancer: a multicentre retrospective study. Lancet Oncol 2024; 25: 1188–201—The appendix of this Article has been corrected as of Oct 30, 2024.

查看原文本刊更多论文

Lancet Oncol 2024; 25: 1188-201 更正

Karpinski MJ, Hüsing J, Claassen K, et al Combining PSMA-PET and PROMISE to redefine disease stage and risk in patients with prostate cancer: a multicentre retrospective study.Lancet Oncol 2024; 25: 1188-201-本文附录已于2024年10月30日更正。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

The Lancet Oncology

自引率

0.00%

发文量